logo

For the Inventor, By the Inventor

Pantin, France

Jean G Teutsch

This inventor holds 19 USPTO granted patents, primarily in Steroid Chemistry. Top assignees: Roussel Uclaf, Roussel-Ulcaf. Active years: 1979-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean G Teutsch. Retrieved from https://idiyas.com/inventor/jean-g-teutsch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 9

Forward Citations = 328(Granted Patents)


Location History:

  • Le Blanc-Mesnil, FR (1979 - 1981)
  • Pantin, FR (1980 - 1998)

Company Filing History:

goldMedal18 out of 854 
 
Roussel Uclaf
 patents
silverMedal1 out of 5 
 
Roussel-Ulcaf
 patents

Years Active: 1979-1998

Loading Chart...
Areas of Expertise:
Steroid Derivatives
3-Keto-19-Nor-Steroids
Novel Steroids
Epoxidation Agent
Pregnane Compounds
Androstenes
Estratrienes
Chloro-Acetylenic Steroids
Substituted Estradienes
Preparation Process
Intermediates
Phenylimidazolidines
19 patents (USPTO):Explore Patents
1. 5750553 - Optionally substituted phenylimidazolidines, their preparation process (1998-05-12),
2. 5182381 - Intermediates for 3-keto-19-nor-.DELTA..sup.4,9 -steroids (1993-01-26),
3. 5064822 - Novel 3-keto-19-nor-.DELTA..sup.4,9 -steroids (1991-11-12),
4. 4634695 - Steroid derivatives (1987-01-06),
5. 4540686 - 3-Keto-19-nor-.DELTA..sup.4,9 -steroids (1985-09-10),
6. 4519946 - Steroids (1985-05-28),
7. 4515787 - Steroids (1985-05-07),
8. 4477445 - 3-Keto-19-nor-.DELTA.4,9-steroids (1984-10-16),
9. 4447424 - Steroid derivatives (1984-05-08),
10. 4386085 - Novel steroids (1983-05-31),
11. 4353899 - Novel 16.alpha.-methyl-pregnane (1982-10-12),
12. 4303654 - Novel 21-chloro-20-acetylenic steroids (1981-12-01),
13. 4272530 - .DELTA..sup.1,3,5(10) -Estratrienes (1981-06-09),
14. 4257948 - Novel epoxidation agent and process (1981-03-24),
15. 4233297 - Novel .DELTA..sup.4 -androstenes (1980-11-11),

Title: Jean G. Teutsch: Innovator in Pharmaceutical Chemistry

Introduction

Jean G. Teutsch, a prominent figure in the field of pharmaceutical chemistry, is based in Pantin, France. With an impressive portfolio of 19 patents, Teutsch has made significant contributions to the development of innovative compounds with therapeutic applications. His research primarily focuses on steroid derivatives and their biological activities.

Latest Patents

Among his latest patents, Teutsch has developed optionally substituted phenylimidazolidines and their preparation process. He has also worked on intermediates for 3-keto-19-nor-Δ4,9-steroids, providing novel compounds that exhibit remarkable antiglucocorticoidal activity. These inventions have potential applications in the medical field, particularly in the treatment of conditions related to glucocorticoid function.

Career Highlights

Teutsch has been associated with notable companies such as Roussel Uclaf, where he honed his skills in drug development and pharmaceutical research. His contributions have played a pivotal role in advancing therapeutic options in the industry.

Collaborations

During his career, Jean G. Teutsch has collaborated with esteemed professionals in the field, including Roger Deraedt and Daniel Philibert. These partnerships have not only fostered innovation but also contributed to the successful realization of various projects and patents.

Conclusion

Jean G. Teutsch continues to be an influential inventor in the pharmaceutical domain, with a strong focus on advancing medical science through his innovative patents. His work is a testament to the importance of research and collaboration in the development of new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…